Twist Bioscience Corp’s recent filing unveils that its Chief Accounting Officer WERNER ROBERT F. unloaded Company’s shares for reported $5276.0 on Aug 04 ’25. In the deal valued at $28.36 per share,186 shares were sold. As a result of this transaction, WERNER ROBERT F. now holds 49,780 shares worth roughly $1.38 million.
Then, Leproust Emily M. sold 5,585 shares, generating $158,413 in total proceeds. Upon selling the shares at $28.36, the Chief Executive Officer now owns 639,721 shares.
Before that, Green Paula sold 1,255 shares. Twist Bioscience Corp shares valued at $35,597 were divested by the SVP of Human Resources at a price of $28.36 per share. As a result of the transaction, Green Paula now holds 126,206 shares, worth roughly $3.49 million.
Wolfe Research initiated its Twist Bioscience Corp [TWST] rating to an Outperform in a research note published on December 13, 2024; the price target was $60. A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in early June with a ‘”a Buy”‘ rating. Goldman also remained covering TWST and has increased its forecast on January 17, 2024 with a “Buy” recommendation from previously “Neutral” rating. Berenberg started covering the stock on September 27, 2023. It rated TWST as “a Buy”.
Price Performance Review of TWST
On Monday, Twist Bioscience Corp [NASDAQ:TWST] saw its stock jump 7.76% to $27.63. Over the last five days, the stock has lost -8.54%. Twist Bioscience Corp shares have fallen nearly -37.98% since the year began. Nevertheless, the stocks have fallen -40.54% over the past one year. While a 52-week high of $55.33 was reached on 01/24/25, a 52-week low of $24.28 was recorded on 08/07/25.
Levels Of Support And Resistance For TWST Stock
The 24-hour chart illustrates a support level at 26.19, which if violated will result in even more drops to 24.75. On the upside, there is a resistance level at 28.38. A further resistance level may holdings at 29.13.
How much short interest is there in Twist Bioscience Corp?
A steep rise in short interest was recorded in Twist Bioscience Corp stocks on 2025-07-15, growing by 0.44 million shares to a total of 10.75 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 10.31 million shares. There was a rise of 4.06%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on January 05, 2023 when Scotiabank began covering the stock and recommended ‘”a Sector outperform”‘ rating along with a $33 price target.
